Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine in Severe COVID-19 (PISCO)
NCT04343963Phase 3Unknown
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Apr 2020
- Primary completion
- Sep 2020
- Countries
- 1
01
Overview
A Phase 3 trial of pyridostigmine in coronavirus disease 2019 (COVID-19), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Status: unknown.
02
Drugs
pyridostigmine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04343963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04343963.